On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Pharmaceutical studies and practices

TopicLeading institutions, researchers & key papers

Pharmaceutical studies and practices is a topic indexed in ScholarIQ from OpenAlex.

What is known about Pharmaceutical studies and practices?

ScholarIQrecord summary

This cluster of papers focuses on the developmental pharmacology and pediatric drug use, including topics such as off-label drug use, adverse drug reactions, clinical trials, pediatric formulations, medication adherence, regulatory framework, and neonatal intensive care. It addresses the challenges and considerations specific to drug disposition, action, and therapy in infants and children.

How many works does Pharmaceutical studies and practices have?

ScholarIQindexed works

Pharmaceutical studies and practices has 220 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Pharmaceutical studies and practices?

ScholarIQopenalex

The OpenAlex for Pharmaceutical studies and practices is on the source record.

What are the most-cited papers on Pharmaceutical studies and practices?

ScholarIQmost cited works
The Pharmacological Basis of Therapeutics, 7th ed
John L. Egle
Journal of Pharmaceutical Sciences. 1986928 Citations
Standard 6: Age Groups for Pediatric Trials
Katrina Williams, Denise Thomson, Iva Seto, Despina G. Contopoulos‐Ioannidis, John P. A. Ioannidis, Sarah Curtis, Evelyn Constantin, Gitanjali Batmanabane, Lisa Hartling, Terry P. Klassen
PEDIATRICS. 2012543 Citations
[The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use].
Jean‐Paul Boissel, Michel Cucherat, Wei Li, Gilles Châtellier, François Gueyffier, Marc Buyse, Florent Boutitie, Patrice Nony, M. Haugh, G Mignot
PubMed. 2000534 Citations
Drug dosing consideration in patients with acute and chronic kidney disease—a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
Gary R. Matzke, George R. Aronoff, Arthur J. Atkinson, William M. Bennett, Brian S. Decker, Kai‐Uwe Eckardt, Thomas A. Golper, Darren W. Grabe, Bertram L. Kasiske, Frieder Keller, Jan T. Kielstein, Ravindra L. Mehta, Bruce A. Mueller, Deborah A. Pasko, Franz Schaefer, Domenic A. Sica, Lesley A. Inker, Jason G. Umans, Patrick Murray
Kidney International. 2011458 CitationsOPEN ACCESS
Outcome Reporting in Industry-Sponsored Trials of Gabapentin for Off-Label Use
S. Swaroop Vedula, Lisa Bero, Roberta W. Scherer, Kay Dickersin
New England Journal of Medicine. 2009367 Citations

Where is Pharmaceutical studies and practices research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Pharmaceutical studies and practices is open access?

ScholarIQopen access share
33%OPEN ACCESS
Gold
7%
Green
20%
Hybrid
7%
Bronze
0%
Closed
67%

Related on ScholarIQ

470M+ articles · 14-day free trial